Haemonetics | HAE - Ebitda





Ebitda Veränderung Datum
Baxter International USD 309M 756M 2026-03
Becton, Dickinson and Co. USD 1.71B 1B 2026-06
Boston Scientific USD 1.63B 27M 2026-06
Cooper Companies USD 323.4M 13.2M 2025-12
Fresenius EUR 988M 37M 2026-06
Fresenius Medical Care EUR 843.66M 19.66M 2026-06
Globus Medical USD 279.84M 48.01M 2026-06
Haemonetics USD 96.17M 91.87M 2026-06
ICU Medical USD 110.03M 11.35M 2026-06
Intuitive Surgical USD 1.06B 29.9M 2026-03
Medtronic USD 2.81B 119M 2026-03
Merit Medical Systems USD 104.39M 10.97M 2026-06
Neogen USD 45.4M 2.8M 2026-03
OraSure Technologies USD -17.7M 4.06M 2025-12
Plus Therapeutics USD -4.4M 2.94M 2025-09
Quidel USD 129.3M 20.6M 2026-06
ResMed USD 559.78M 9.06M 2026-06
STAAR Surgical USD 20M 387K 2026-06
Steris USD 443M 48.3M 2026-03
Stryker USD 1.93B 357M 2026-06
Teleflex USD 75.63M 171.44M 2026-03
Terumo JPY 116.67B 58.79B 2026-06
Thermo Fisher Scientific USD 3.55B 845M 2026-06
US Physical Therapy USD 26.95M 7.6M 2026-06
Zimmer Biomet Holdings USD 830.5M 190.4M 2026-06